In this new edition to Edward Elgar Publishing's "Research Handbooks in
European Law" series, Tamara Law and Policy can be treated as an educational tool -particularly for those in the UK -to uncover the EU's growing contributions to health law and policy, though one is doubtful how many Brexit voters will read this book or any other book in the Elgar European Law series. Indeed, this Research Handbook is not geared primarily to a UK populace ignorant "of all things European". Instead, it has a broader purpose. As the editors observe, "[w]hatever the future relationship between the UK and the EU, and whichever way the EU itself develops, the EU's involvement with health law and policy will continue" (p. 1).
What the editors seek to do is offer, from a variety of disciplinary perspectives, including law, political science, policy studies, and sociology, 1) expert views on the current status of EU health law and policy, and 2) horizon scanning on what future directions they may take. This is a book aimed at readers interested in European health law and policy on a continental level, EU institutional level, and indeed even a global level.
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Not surprisingly in such a large edited collection, some chapters are stronger than others, and several shine with their adept analysis and clear writing. Foremost, the editors provide a brilliant and beautifully written introduction. Hervey, Young, and Bishop discern three broad themes in their book:
• "Fractured decision-making, leading to policy ineffectiveness or incoherence" (p. 6). That is, pursuing health agendas within the EU's institutional structures is "complicated by the actors and the decisionmaking processes involved" (p. 6), which are dispersed among different institutional settings.
• "The place of 'science' and 'innovation' in EU health law and policy" (p. 7). As several of the contributing authors suggest, the EU has struggled to balance effectively the (societal) desire to enable novel technological developments and protecting the interests and welfare of patients, health systems, and others.
• "The fragility and frustrated potential of EU health law and policy, and yet its remarkable durability [:] …although EU health law and policy may be seen as long-standing, it is also seen as precarious" (p. 9). Related to the second theme, here the editors highlight concerns with constitutional asymmetry in EU law, where "the logic of the market stands in a hierarchical relationship above other logics" (p. 9), i.e. health may stand in a non-equal relationship to market-based values.
The editors suggest that one potential direction in EU health law and policy is an increased focus on human rights -which would see the protection and promotion of health as a central value of EU law and policy (pp. 10-11). demographic ageing and the shift towards chronic health conditions. This will lead to spiralling costs in health systems. The authors equivocate as to whether this will result mainly in cost cutting or in new and/or common solutions across the EU.
A second excellent chapter worth highlighting is Markus Frischhut and Scott L. Greer's chapter on "EU public health law and policy -communicable diseases", which opens Part IV on Public Health (and which, in my opinion, is the strongest Part of the Research Handbook). Here, Frischhut and Greer present the historic development of EU communicable disease control law and policy since the 1990s. They write with noted disappointment that the EU hitherto has been a weak actor in public health law. This is largely "because it lacks coercive capabilities such as quarantine or distributive powers such as vaccination programmes". However, they write more optimistically that with the strength of its human rights law and its "increasing role in setting norms of good practice for public health", it is "increasingly, slowly, being drawn into the debates about privacy, coercion and proportionality that mark communicable disease control law in most States" (p. 316). Ultimately, Frischhut and Greer paint a story of a developing network in the EU that plays a more effective role in communicable disease control. Yet political and legal challenges remain, foremost in regards to risk management and response, given that the EU "has very weak Treaty powers and Member States have deep conflicting incentives and responses" (p. 328).
Overall, this Research Handbook on EU Health Law and Policy is a welcome addition to the libraries of EU health lawyers and policymakers. A small criticism is that the editors and authors alike could have been clearer in demarcating the (albeit fluid) boundaries between law and policy. Interested readers will dip into chapters that appeal to their needs and interests, and the well-constructed bibliography and helpful glossary will appeal to keen and novice EU health law and policy scholars alike. I am pleased that despite the precarious future of the UK's relationship with the EU, the editors offer an optimistic outlook -at least insofar as the EU is concerned: "If the reasons for the EU institutions not having pursued health agendas in the past, despite formal legal competence and sufficient resources, lie in the political preferences of governments of powerful Member States, an EU without the UK may offer altered possibilities" (p. 11).
Indeed. And a contrario, one can read into this quote a foreboding sense of concern about the UK's diminished role in Europe and the world, coupled with a lingering worry over the predominance of market-based values that subordinate health values and public interests.
